Literature DB >> 19441088

Screening options for Down syndrome: how women choose in real clinical setting.

T K Lo1, F K Lai, W C Leung, W L Lau, L S Ng, W C Wong, S S Tam, Y C Yee, H Choi, H S W Lam, A S Y Sham, L C H Tang, R K H Chin.   

Abstract

OBJECTIVE: To study pregnant women's preference among various screening options for Down syndrome (DS) in routine clinical setting, and its potential association with women's demographic characteristics.
METHODS: Women aged 35 years and older carrying singleton pregnancy were offered a variety of screening tests for DS before 14 weeks of gestation. Their preference was confirmed by the test they actually underwent. The association between women's choice of test and a number of demographic characteristics was studied using multinomial regression.
RESULTS: Among 1967 eligible women, 619 opted for first-trimester screening test (FTS), 924 for partial integrated test (PIT), and 424 for full integrated test (FIT). Nulliparous women and working mothers were more likely to choose FTS and FIT. Women with history of subfertility were more likely to choose FIT. Women with family history of chromosomal abnormalities were more likely to choose FTS. The choice of screening test could be predicted for 49.9% of women using four demographic characteristics.
CONCLUSIONS: Among older women of predominantly Chinese ethnicity, integrated test is a favorite alternative to FTS. Their choice of DS screening test can be predicted by their obstetric and socioeconomic characteristics. Many women show willingness to pay for a test with a lower false-positive rate.

Entities:  

Mesh:

Year:  2009        PMID: 19441088     DOI: 10.1002/pd.2292

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  1 in total

1.  Prenatal diagnosis and termination of pregnancy: perspectives of South African parents of children with Down syndrome.

Authors:  Chantelle Jennifer Scott; Merle Futter; Ambroise Wonkam
Journal:  J Community Genet       Date:  2012-10-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.